KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Thermo Fisher Scientific (TMO) Receivables - Net (2016 - 2025)

Thermo Fisher Scientific's Receivables - Net history spans 17 years, with the latest figure at $8.9 billion for Q4 2025.

  • For the quarter ending Q4 2025, Receivables - Net rose 8.66% year-over-year to $8.9 billion, compared with a TTM value of $8.9 billion through Dec 2025, up 8.66%, and an annual FY2025 reading of $8.9 billion, up 8.66% over the prior year.
  • Receivables - Net for Q4 2025 was $8.9 billion at Thermo Fisher Scientific, roughly flat from $8.9 billion in the prior quarter.
  • The five-year high for Receivables - Net was $8.9 billion in Q3 2025, with the low at $5.5 billion in Q3 2021.
  • Average Receivables - Net over 5 years is $7.8 billion, with a median of $8.0 billion recorded in 2021.
  • Year-over-year, Receivables - Net soared 42.04% in 2022 and then fell 1.37% in 2024.
  • Tracing TMO's Receivables - Net over 5 years: stood at $8.0 billion in 2021, then increased by 1.73% to $8.1 billion in 2022, then increased by 1.31% to $8.2 billion in 2023, then dropped by 0.36% to $8.2 billion in 2024, then rose by 8.66% to $8.9 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Receivables - Net are $8.9 billion (Q4 2025), $8.9 billion (Q3 2025), and $8.6 billion (Q2 2025).